10-Q Filing

BNB PLUS CORP. CIK: 744452 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-091414`
Period End Date	20200630
Filing Date	20200806
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	apdn-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 71 Cash Flow Statement 70 Stockholders Equity 40

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$26.13K	USD	Point-in-time
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.50K	USD	Point-in-time
Accounts payable and accrued liabilities, related parties (in dollars)	`AccountsPayableRelatedPartiesCurrentAndNoncurrent`	$27.10K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.92M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$558.99K	USD	Point-in-time
Accounts receivable, net of allowance of $26,131 at June 30, 2020 and $4,500 at September 30, 2019, respectively	`AccountsReceivableNetCurrent`	$839.95K	USD	Point-in-time
Accounts receivable, net of allowance of $26,131 at June 30, 2020 and $4,500 at September 30, 2019, respectively	`AccountsReceivableNetCurrent`	$231.19K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$142.63K	USD	Point-in-time
Inventories	`InventoryNet`	$444.64K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$554.69K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$604.74K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.16M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.15M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$226.22K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$750.53K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	1.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	4.97M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.97M	shares	Point-in-time
Deferred offering costs	`DeferredCosts`	$109.70K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$95.03K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$62.35K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$734.77K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$688.59K	USD	Point-in-time
Total Assets	`Assets`	$13.98M	USD	Point-in-time
Total Assets	`Assets`	$3.56M	USD	Point-in-time
Accounts payable and accrued liabilities (including related party of $27,097 at June 30, 2020)	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.62M	USD	Point-in-time
Accounts payable and accrued liabilities (including related party of $27,097 at June 30, 2020)	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.64M	USD	Point-in-time
Promissory notes payable-current portion	`NotesPayableToBankCurrent`	$376.35K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$431.21K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$628.99K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.25M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$621.97K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$785.43K	USD	Point-in-time
Promissory notes payable-long term portion	`NotesPayableToBankNoncurrent`	$470.44K	USD	Point-in-time
Secured convertible notes payable, related party. net of debt issuance costs	`ConvertibleLongTermNotesPayable`	$1.49M	USD	Point-in-time
Secured convertible notes payable, related party. net of debt issuance costs	`ConvertibleLongTermNotesPayable`	$1.44M	USD	Point-in-time
Secured convertible notes payable, recorded at fair value	`SecuredConvertibleNotesPayableNoncurrentFairValueDisclosures`	$102.78K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.20M	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2020 and September 30, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2020 and September 30, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 500,000,000 shares authorized; 4,968,197 and 1,207,993 shares issued and outstanding as of June 30, 2020 and September 30, 2019, respectively	`CommonStockValue`	$4.97K	USD	Point-in-time
Common stock, par value $0.001 per share; 500,000,000 shares authorized; 4,968,197 and 1,207,993 shares issued and outstanding as of June 30, 2020 and September 30, 2019, respectively	`CommonStockValue`	$1.21K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$274.49M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$255.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-256.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-265.71M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity (deficit):	`StockholdersEquity`	$-841.46K	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity (deficit):	`StockholdersEquity`	$8.79M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-7.04K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-6.51K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$766.02K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$754.50K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.79M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-734.36K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.78M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Total liabilities and equity (deficit)	`LiabilitiesAndStockholdersEquity`	$3.56M	USD	Point-in-time
Total liabilities and equity (deficit)	`LiabilitiesAndStockholdersEquity`	$13.98M	USD	Point-in-time

Income Statement 71 line items

Line Item	Tag	Value	Unit	Period
Interest (expense) income, related party interest	`InterestIncomeRelatedParty`	$75.58K	USD	3 Qtrs
Interest (expense) income, related party interest	`InterestIncomeRelatedParty`	$26.27K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.62M	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.05M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$3.72M	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$431.52K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$566.42K	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$270.88K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$557.51K	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$154.80K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.59M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$7.25M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.02M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.41M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.08M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$719.67K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.08M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$814.60K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$203.47K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$61.87K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$320.04K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$87.31K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$9.53M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$3.21M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.47M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$10.42M	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-8.48M	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-1.43M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-3.19M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-7.26M	USD	3 Qtrs
Interest expense (including related parties interest of $26,267 and $75,577 for the three and six months ended June 30, 2019, respectively)	`InterestIncomeExpenseNet`	$-107.21K	USD	3 Qtrs
Interest expense (including related parties interest of $26,267 and $75,577 for the three and six months ended June 30, 2019, respectively)	`InterestIncomeExpenseNet`	$-28.62K	USD	1 Quarter
Interest expense (including related parties interest of $26,267 and $75,577 for the three and six months ended June 30, 2019, respectively)	`InterestIncomeExpenseNet`	$-38.18K	USD	1 Quarter
Interest expense (including related parties interest of $26,267 and $75,577 for the three and six months ended June 30, 2019, respectively)	`InterestIncomeExpenseNet`	$-86.81K	USD	3 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-8.10K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-334.53K	USD	3 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-72.69K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-31.36K	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.90M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.40M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.29M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.48M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.66M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-3.29M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.69M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-3.23M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.95M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-1.48M	USD	1 Quarter
Less: Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$528.00	USD	3 Qtrs
Less: Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-662.00	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-3.29M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-7.40M	USD	3 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-8.90M	USD	3 Qtrs
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$-2.84K	USD	3 Qtrs
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.29M	USD	1 Quarter
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.91M	USD	3 Qtrs
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.48M	USD	1 Quarter
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.40M	USD	3 Qtrs
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.46	USD	3 Qtrs
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.72	USD	1 Quarter
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.54	USD	3 Qtrs
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.55	USD	1 Quarter
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.51M	shares	3 Qtrs
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.58M	shares	1 Quarter
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	874,272.00	shares	3 Qtrs
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	952,835.00	shares	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Proceeds from senior convertible notes payable, related party	`ProceedsFromRelatedPartyDebt`	$550.00K	USD	3 Qtrs
Proceeds from senior convertible notes payable, related party	`ProceedsFromRelatedPartyDebt`	$550.00K	USD	3 Qtrs
Interest paid in kind, related party	`PaidInKindInterestRelatedParty`	$51.82K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$203.47K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$232.72K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$797.58K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$757.34K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$6.69K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$19.20K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$4.83K	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$-8.63K	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$21.88K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-586.88K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$93.31K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$302.01K	USD	3 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-17.37K	USD	3 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-37.39K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$157.49K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-402.78K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-151.44K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-197.78K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.80M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.16M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.66K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$63.99K	USD	3 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	$36.52K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-63.99K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-56.18K	USD	3 Qtrs
Proceeds from Promissory notes (related parties $550,000)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	3 Qtrs
Proceeds from Promissory notes (related parties $550,000)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$550.00K	USD	3 Qtrs
Proceeds from Promissory notes	`ProceedsFromNotesPayable`	$846.79K	USD	3 Qtrs
Proceeds from Promissory notes	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromIssuanceOfWarrants`	$7.20M	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromIssuanceOfWarrants`	$718.06K	USD	3 Qtrs
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$10.64M	USD	3 Qtrs
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$2.48M	USD	3 Qtrs
Repayment of convertible notes	`ProceedsFromSecuredConvertibleNotesPayable`	$-107.80K	USD	3 Qtrs
Repayment of convertible notes	`ProceedsFromSecuredConvertibleNotesPayable`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.75M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.58M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-118.42K	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$10.37M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.66M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.92M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$507.15K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.66M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.92M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$507.15K	USD	Point-in-time
Cash paid during period for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid during period for interest	`InterestPaidNet`	$45.35K	USD	3 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Impact of adoption of new accounting pronouncements included in accumulated deficit	`ImpactOfAdoptionOfNewAccountingPronouncementsIncludedInAccumulatedDeficitNonCashFinancingActivities`	-	USD	3 Qtrs
Impact of adoption of new accounting pronouncements included in accumulated deficit	`ImpactOfAdoptionOfNewAccountingPronouncementsIncludedInAccumulatedDeficitNonCashFinancingActivities`	$493.22K	USD	3 Qtrs
Interest paid in kind (related party of $51,824 for the nine month period ended June 30, 2019)	`PaidInKindInterest`	$48.82K	USD	3 Qtrs
Interest paid in kind (related party of $51,824 for the nine month period ended June 30, 2019)	`PaidInKindInterest`	$35.62K	USD	3 Qtrs
Offering costs incurred, and included in accounts payable	`OfferingCostsIncurredAndIncludedInAccountsPayable`	$15.93K	USD	3 Qtrs
Offering costs incurred, and included in accounts payable	`OfferingCostsIncurredAndIncludedInAccountsPayable`	-	USD	3 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	-	USD	3 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$611.05K	USD	3 Qtrs
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	$2.84K	USD	3 Qtrs
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	-	USD	3 Qtrs
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	-	USD	3 Qtrs
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	$109.70K	USD	3 Qtrs
Intangible asset costs incurred, and included in accounts payable	`IntangibleAssetCostsIncurredAndIncludedInAccountsPayable`	-	USD	3 Qtrs
Intangible asset costs incurred, and included in accounts payable	`IntangibleAssetCostsIncurredAndIncludedInAccountsPayable`	$14.38K	USD	3 Qtrs

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$766.02K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$754.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.79M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-734.36K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.78M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.97M	shares	Point-in-time
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-10.53M	USD	1 Quarter
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-2.26M	USD	1 Quarter
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-201.22K	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$-269.44K	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$-4.44M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$2.77M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$-718.06K	USD	1 Quarter
Impact of adoption of new accounting pronouncements included in accumulated deficit	`ImpactOfAdoptionOfNewAccountingPronouncementsIncludedInAccumulatedDeficit`	$-493.22K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$364.82K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$205.49K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$227.27K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$154.30K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$267.09K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$490.24K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.29M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.69M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.23M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.48M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$766.02K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$754.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.79M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-734.36K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.78M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.97M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.